ChengDu ShengNuo Biotec Co.,Ltd. (688117.SS)
CNY 27.72
(0.84%)
CNY 27.72
(0.84%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 86.52 Million | 95.62 Million | 52.41 Million | 80.84 Million | 30.91 Million | 66.22 Million |
| Net Income | 70.33 Million | 64.48 Million | 61.25 Million | 59.99 Million | 48.13 Million | 29.86 Million |
| Depreciation & Amortization | 29.13 Million | 24.68 Million | 18.26 Million | 17.06 Million | 13.12 Million | 12.29 Million |
| Deferred income taxes | -1.26 Million | 690.49 Thousand | -39.8 Thousand | -937.5 Thousand | -884.8 Thousand | -383.1 Thousand |
| Stock-based compensation | 2.85 Million | 1.11 Million | 1.11 Million | - | 978.57 Thousand | 756.07 Thousand |
| Change in working capital | -35.33 Million | -2.63 Million | -35.46 Million | -5.34 Million | -40.71 Million | 17.6 Million |
| Other non-cash items | 117.26 Million | 7.28 Million | 7.29 Million | 9.11 Million | 10.28 Million | 6.46 Million |
| Investing Cash Flow | -370.87 Million | 20.96 Million | -281.91 Million | -51.78 Million | -30.02 Million | -31.36 Million |
| Investments in PPE | -277.98 Million | -135.85 Million | -64.22 Million | -51.95 Million | -30.84 Million | -31.36 Million |
| Acquisitions | 511.56 Thousand | 130.72 Thousand | 111.65 Thousand | 177.97 Thousand | 819.37 Thousand | - |
| Investment purchases | -462.02 Million | -47.7 Million | -9.9 Million | - | - | - |
| Sales/Maturities of investments | 368.62 Million | 4.38 Million | 1.51 Million | - | - | - |
| Other Investing Activities | -50 Million | 200 Million | -209.41 Million | 0.64 | 0.21 | -31.36 Million |
| Financing Cash Flow | 129.57 Million | 42.24 Million | 312.19 Million | -3.63 Million | -16.18 Million | 48.73 Million |
| Debt repayment | -159.68 Million | -30 Million | -30 Million | -318.8 Thousand | -10 Million | -10 Million |
| Dividends payments | -20 Million | -24 Million | -25 Thousand | - | -401.16 Thousand | -415.59 Thousand |
| Common Stock Repurchased | - | - | -4.15 Million | - | - | - |
| Common Stock Issuance | - | - | -25.84 Million | - | - | - |
| Other Financing Activities | -9.18 Million | 99.06 Million | 372.22 Million | -3.31 Million | -5.78 Million | 59.15 Million |
| Accounts receivables | 9.82 Million | -22.21 Million | -17.6 Million | -8.52 Million | -28.2 Million | -19.75 Million |
| Accounts payables | 18.63 Million | 57.6 Million | -5.27 Million | 13.72 Million | 5.03 Million | 50.01 Million |
| Inventory | -63.79 Million | -38.71 Million | -12.54 Million | -9.6 Million | -16.66 Million | -12.27 Million |
| Other working capital | 2.85 Million | 690.49 Thousand | -39.8 Thousand | -937.45 Thousand | -884.83 Thousand | 29.87 Million |
| Cash at beginning of period | 372.12 Million | 210.29 Million | 128.25 Million | 102.94 Million | 118.82 Million | 34.02 Million |
| Cash at end of period | 219.12 Million | 372.12 Million | 210.29 Million | 128.25 Million | 102.94 Million | 118.82 Million |
| Capital Expenditure | -277.98 Million | -135.85 Million | -64.22 Million | -51.95 Million | -30.84 Million | -31.36 Million |
| Effect of forex changes on cash | 503.31 Thousand | 2.99 Million | -665.63 Thousand | -117.22 Thousand | -586.98 Thousand | 1.2 Million |
| Net cash flow / Change in cash | -152.99 Million | 161.82 Million | 82.03 Million | 25.3 Million | -15.87 Million | 84.8 Million |
| Free Cash Flow | -191.45 Million | -40.23 Million | -11.8 Million | 28.88 Million | 75.42 Thousand | 34.86 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 35.15 Million | 5.31 Million | 16.47 Million | 70.33 Million | 35.54 Million | 14.64 Million |
| Depreciation & Amortization | - | 7.84 Million | 7.84 Million | 29.13 Million | 7.49 Million | -13.36 Million |
| Deferred income taxes | 2.06 Million | - | - | -1.26 Million | - | -9.61 Million |
| Stock-based compensation | - | 3.14 Million | - | 2.85 Million | 2.85 Million | -64.63 Thousand |
| Change in working capital | - | -22.76 Million | - | -35.33 Million | -51.11 Million | 22.61 Million |
| Other non-cash items | -36.43 Million | 17.74 Million | -4.38 Million | 117.26 Million | 26.1 Million | 11.3 Thousand |
| Investing Cash Flow | -91.19 Million | -12.67 Million | -101.26 Million | -370.87 Million | -54.34 Million | -140.54 Million |
| Investments in PPE | -36.01 Million | -68.01 Million | -67.63 Million | -277.98 Million | -79.85 Million | -98.57 Million |
| Acquisitions | - | - | - | 511.56 Thousand | 511.56 Thousand | 0.42 |
| Investment purchases | 184.65 Million | -193.7 Million | - | -462.02 Million | -73.62 Million | -92.4 Million |
| Sales/Maturities of investments | 69.86 Thousand | 214.49 Million | 910 Thousand | 368.62 Million | 98.62 Million | 50.42 Million |
| Other Investing Activities | -55.25 Million | 34.54 Million | -34.54 Million | -50 Million | 25.63 Million | - |
| Financing Cash Flow | 4.09 Million | 68.12 Million | 33.33 Million | 129.57 Million | -6.67 Million | 5.08 Million |
| Debt repayment | -8.5 Million | -93.83 Million | -35.24 Million | -159.68 Million | -212.68 Million | -2 Million |
| Dividends payments | -4.18 Million | -25.47 Million | -1.84 Million | -20 Million | -2.43 Million | -2.38 Million |
| Common Stock Repurchased | - | - | - | - | -216.69 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -224.83 Thousand | -25.71 Million | -1.9 Million | -9.18 Million | -218.43 Million | 9.46 Million |
| Accounts receivables | - | 15.88 Million | - | 9.82 Million | 9.82 Million | -21.68 Million |
| Accounts payables | - | - | - | 18.63 Million | - | - |
| Inventory | - | -38.65 Million | - | -63.79 Million | -63.79 Million | 44.3 Million |
| Other working capital | - | - | - | 2.85 Million | 2.85 Million | - |
| Cash at beginning of period | 232.84 Million | 165.24 Million | 219.12 Million | 372.12 Million | 225.71 Million | 345.55 Million |
| Cash at end of period | 146.39 Million | 236.01 Million | 165.24 Million | 219.12 Million | 219.12 Million | 224.43 Million |
| Capital Expenditure | -36.01 Million | -68.01 Million | -67.63 Million | -277.98 Million | -79.85 Million | -98.57 Million |
| Effect of forex changes on cash | -66.43 Thousand | 114.83 Thousand | 57.06 Thousand | 503.31 Thousand | 296.81 Thousand | 118.63 Thousand |
| Net cash flow / Change in cash | -86.44 Million | 70.77 Million | -53.88 Million | -152.99 Million | -6.58 Million | -121.11 Million |
| Free Cash Flow | -35.22 Million | -52.79 Million | -55.54 Million | -191.45 Million | -25.71 Million | -84.34 Million |
EFF
5519
ALAR
1320
688660
600636